Larkberget

Larkberget P/CF

The P/CF (Price-to-Cash-Flow Ratio) of Larkberget (LARK.ST) as of Oct 17, 2026 is -3.81. In the previous year, P/CF (Price-to-Cash-Flow Ratio) was -1.63 — a change of 134.34% (lower).

P/CF

-3.81

YoY

134.34%

Last updated:

P/CF (Price-to-Cash-Flow Ratio) of Larkberget is 2025 -3.81 . P/CF (Price-to-Cash-Flow Ratio) of Larkberget was 2024 -1.63 . It decreases by 134.34% lower compared to the previous year.

The Larkberget P/CF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/CF
Date
P/CF
Jan 1, 2018
214.02 SEK
Jan 1, 2019
-2.25 SEK
Jan 1, 2020
-1.27 SEK
Jan 1, 2021
2.20 SEK
Jan 1, 2022
-2.92 SEK
Jan 1, 2023
-1.59 SEK
Jan 1, 2024
-1.63 SEK
Jan 1, 2025
-3.81 SEK
The Larkberget P/CF history
YEARP/CFYoY
-3.81+134.34%
-1.63+2.03%
-1.59-45.46%
-2.92-232.70%
2.20-273.39%
-1.27-43.66%
-2.25-101.05%
214.02-4,286.09%
-5.11-7.55%
-5.53-28.64%
-7.75-90.13%
-78.48—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Larkberget Stock analysis

What does Larkberget do? Larkberget AB, trading under the ticker LARK.ST, is a biotechnology company based in Lidingoe, Sweden. The company, which is listed on the Stockholm Stock Exchange, went public through an IPO on May 25, 2015. Larkberget AB operates within the health care sector, specifically in the biotechnology industry. The company's website is https://combigene.com/. According to the provided information, Larkberget AB is engaged in the development of new treatments for neurological diseases. The firm's platform involves the use of gene therapy vectors to deliver combinations of transgenes encoding neuropeptide Y (NPY) receptors, galanin, galanin receptors, somatostatin, and somatostatin receptors. These vectors are designed for the treatment of neurological and psychiatric diseases in both humans and animals. The company focuses on developing an epilepsy treatment using an adeno-associated virus (AAV) vector that carries transgenes for the neurotransmitter NPY and its receptor, the G protein-coupled receptor Y2. The company's headquarters are located in Lidingoe, near Stockholm. Larkberget is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Larkberget stock

P/CF (Price-to-Cash-Flow Ratio) of Larkberget is -3.81 in 2025.

P/CF (Price-to-Cash-Flow Ratio) of Larkberget changed from -1.63 to -3.81, representing a 134.34% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/CF (Price-to-Cash-Flow Ratio) Larkberget since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Cash-Flow ratio measures the stock price relative to operating cash flow per share. Unlike P/E, it is harder to manipulate as cash flow is less subject to accounting adjustments.

P/CF = Stock Price / Operating Cash Flow per Share

To evaluate P/CF (Price-to-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/CF (Price-to-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/CF (Price-to-Cash-Flow Ratio)'s Larkberget with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Larkberget

All Key Metrics — Larkberget